Travere Therapeutics (TVTX)
NASDAQ:TVTX
Advertisement

Travere Therapeutics (TVTX) Revenue

Compare
530 Followers

Travere Therapeutics Revenue

Travere Therapeutics had a revenue of 164.86M in the quarter ending Sep 30, 2025, with 44.05%. This bring the company's revenue in the last twelve months to 435.83M, Decreased 30.54%. In the fiscal year ending Dec 31, 2024, Travere Therapeutics had annual revenue of 233.18M with 60.55% growth.
Revenue (ttm)
435.83M
Revenue Growth
114.22%
P/S Ratio
13.24
Revenue/Employee
$605,649
Employees
385
Market Cap
$3.09B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
233.18M87.94M+160.55%
Dec 31, 2023
145.24M-66.78M+68.50%
Dec 31, 2022
212.02M-15.47M+93.20%
Dec 31, 2021
227.49M29.17M+114.71%
Dec 31, 2020
198.32M22.98M+113.11%
Dec 31, 2019
175.34M11.09M+106.75%
Dec 31, 2018
164.25M9.31M+106.01%
Dec 31, 2017
154.94M21.35M+115.98%
Dec 31, 2016
133.59M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis